keyword
https://read.qxmd.com/read/38646872/anti-parkinson-potential-of-hesperetin-nanoparticles-in-vivo-and-in-silico-investigations
#1
JOURNAL ARTICLE
Praveen Kumar Pasala, Mithun Rudrapal, Ranadheer Reddy Challa, Sheikh F Ahmad, Bhaskar Vallamkonda, Ram Babu R
Parkinson's disease (PD) is characterised by the gradual demise of dopaminergic neurons. In recent years, there has been significant interest in herbal treatments. In this study, hesperetin nanoparticles (HTN) were developed and compared their anti-PD potential with hesperetin (HT) on rotenone induced PD rats. Molecular docking was also performed to evaluate the binding affinity of hesperetin on pathological protein, i.e. D2 dopamine receptors (DR2), using Auto Dock Vina tools. The results showed a higher binding relationship of HTN on dopamine receptors (-7...
April 22, 2024: Natural Product Research
https://read.qxmd.com/read/38645778/the-role-of-the-gabaergic-system-on-insomnia
#2
REVIEW
Peeraporn Varinthra, Shameemun Naseer Mohamed Nizarul Anwar, Shu-Ching Shih, Ingrid Y Liu
Sleep is an essential activity for the survival of mammals. Good sleep quality helps promote the performance of daily functions. In contrast, insufficient sleep reduces the efficiency of daily activities, causes various chronic diseases like Alzheimer's disease, and increases the risk of having accidents. The GABAergic system is the primary inhibitory neurotransmitter system in the central nervous system. It transits the gamma-aminobutyric acid (GABA) neurotransmitter via GABAA and GABAB receptors to counterbalance excitatory neurotransmitters, such as glutamate, noradrenaline, serotonin, acetylcholine, orexin, and dopamine, which release and increase arousal activities during sleep...
2024: Tzu chi medical journal
https://read.qxmd.com/read/38645142/bioisosteric-analogs-of-mdma-with-improved-pharmacological-profile
#3
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce Kavanagh, Harald H Sitte
3,4-Methylenedioxymethamphetamine (MDMA, ' ecstasy' ) is re-emerging in clinical settings as a candidate for the treatment of specific psychiatric disorders (e.g. post-traumatic stress disorder) in combination with psychotherapy. MDMA is a psychoactive drug, typically regarded as an empathogen or entactogen, which leads to transporter-mediated monoamine release. Despite its therapeutic potential, MDMA can induce dose-, individual-, and context-dependent untoward effects outside safe settings. In this study, we investigated whether three new methylenedioxy bioisosteres of MDMA improve its off-target profile...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38644789/naloxone-increases-conditioned-fear-responses-during-social-buffering-in-male-rats
#4
JOURNAL ARTICLE
Takumi Yamasaki, Yasushi Kiyokawa, Arisa Munetomo, Yukari Takeuchi
Social buffering is the phenomenon in which the presence of an affiliative conspecific mitigates stress responses. We previously demonstrated that social buffering completely ameliorates conditioned fear responses in rats. However, the neuromodulators involved in social buffering are poorly understood. Given that opioids, dopamine, oxytocin and vasopressin play an important role in affiliative behaviour, here, we assessed the effects of the most well-known antagonists, naloxone (opioid receptor antagonist), haloperidol (dopamine D2 receptor antagonist), atosiban (oxytocin receptor antagonist) and SR49059 (vasopressin V1a receptor antagonist), on social buffering...
April 22, 2024: European Journal of Neuroscience
https://read.qxmd.com/read/38644533/transient-receptor-potential-ankyrin-1-channel-modulates-the-abuse-related-mechanisms-of-methamphetamine-through-interaction-with-dopamine-transporter
#5
JOURNAL ARTICLE
Kwang-Hyun Hur, Youyoung Lee, Audrey Lynn Donio, Seon-Kyung Kim, Bo-Ram Lee, Jee-Yeon Seo, Dooti Kundu, Kyeong-Man Kim, Stephen J Kohut, Seok-Yong Lee, Choon-Gon Jang
BACKGROUND AND PURPOSE: Methamphetamine (METH) use disorder has risen dramatically over the past decade, and there are currently no FDA-approved medications due, in part, to gaps in our understanding of the pharmacological mechanisms related to METH action in the brain. EXPERIMENTAL APPROACH: Here, we investigated whether transient receptor potential ankyrin 1 (TRPA1) mediates each of several METH abuse-related behaviours in rodents: self-administration, drug-primed reinstatement, acquisition of conditioned place preference, and hyperlocomotion...
April 21, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38643909/comparison-of-the-function-of-two-novel-human-dopamine-d2-receptor-variants-identifies-a-likely-mechanism-for-their-pathogenicity
#6
JOURNAL ARTICLE
Dayana Rodriguez-Contreras, Javier García-Nafría, Amy E Chan, Ujwal Shinde, Kim A Neve
Two recently discovered DRD2 mutations, c.634A > T, p.Ile212Phe and c.1121 T > G, p.Met374Arg, cause hyperkinetic movement disorders that have overlapping features but apparently differ in severity. The two known carriers of the Met374Arg variant had early childhood disease onset and more severe motor, cognitive, and neuropsychiatric deficits than any known carriers of the Ile212Phe variant, whose symptoms were first apparent in adolescence. Here, we evaluated if differences in the function of the two variants in cultured cells could explain differing pathogenicity...
April 19, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38643763/transcriptomic-profiling-of-lactotroph-pituitary-neuroendocrine-tumors-via-rna-sequencing-and-ingenuity-pathway-analysis
#7
JOURNAL ARTICLE
Yujiro Hattori, Shigeyuki Tahara, Hitoshi Ozawa, Akio Morita, Hirotaka Ishii
INTRODUCTION: Lactotroph pituitary neuroendocrine tumors (PitNETs) are common pituitary tumors, but their underlying molecular mechanisms remain unclear. This study aimed to investigate the transcriptomic landscape of lactotroph PitNETs and identify potential molecular mechanisms and therapeutic targets through RNA sequencing and ingenuity pathway analysis (IPA). METHODS: Lactotroph PitNET tissues from five surgical cases without dopamine agonist treatment underwent RNA sequencing...
April 20, 2024: Neuroendocrinology
https://read.qxmd.com/read/38642503/conjugation-of-sulpiride-with-a-cell-penetrating-peptide-to-augment-the-antidepressant-efficacy-and-reduce-serum-prolactin-levels
#8
JOURNAL ARTICLE
Yuan Liang, Yu Yang, Ruiyan Huang, Jiangyue Ning, Xingyan Bao, Zelong Yan, Haotian Chen, Li Ding, Chang Shu
Depression ranks as the fourth most prevalent global disease, with suicide incidents occurring at a younger age. Sulpiride (SUL), an atypical antidepressant drug acting as a dopamine D2 receptor antagonist and possessing anti-inflammatory properties, exhibits limited ability to penetrate the blood brain barrier (BBB). This weak penetration hampers its inhibitory effect on prolactin release in the pituitary gland, consequently leading to hyperprolactinemia. In order to enhance the central nervous system efficacy of sulpiride and reduce serum prolactin levels, we covalently linked sulpiride to VPALR derived from the nuclear DNA repair protein ku70...
April 19, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38641041/decoding-the-influence-of-central-leap2-on-food-intake-and-its-effect-on-accumbal-dopamine-release
#9
JOURNAL ARTICLE
Maximilian Tufvesson-Alm, Qian Zhang, Cajsa Aranäs, Sebastian Blid Sköldheden, Christian E Edvardsson, Elisabet Jerlhag
The gut-brain peptide ghrelin and its receptor are established as a regulator of hunger and reward-processing. However, the recently recognized ghrelin receptor inverse agonist, liver-expressed antimicrobial peptide 2 (LEAP2), is less characterized. The present study aimed to elucidate LEAP2s central effect on reward-related behaviors through feeding and its mechanism. LEAP2 was administrated centrally in mice and effectively reduced feeding and intake of palatable foods. Strikingly, LEAP2s effect on feeding was correlated to the preference of the palatable food...
April 17, 2024: Progress in Neurobiology
https://read.qxmd.com/read/38639646/the-analgesic-effects-of-insulin-and-its-disorders-in-streptozotocin-induced-short-term-diabetes
#10
JOURNAL ARTICLE
Ali Mohammad Basatinya, Javad Sajedianfard, Saeed Nazifi, Saied Hosseinzadeh
Evidence suggests that insulin resistance plays an important role in developing diabetes complications. The association between insulin resistance and pain perception is less well understood. This study aimed to investigate the effects of peripheral insulin deficiency on pain pathways in the brain. Diabetes was induced in 60 male rats with streptozotocin (STZ). Insulin was injected into the left ventricle of the brain by intracerebroventricular (ICV) injection, then pain was induced by subcutaneous injection of 2...
April 2024: Physiological Reports
https://read.qxmd.com/read/38639539/dopaminergic-modulation-and-computational-admet-insights-for-the-antidepressant-like-effect-of-n-3-phenylselanyl-prop-2-yn-1-yl-benzamide
#11
JOURNAL ARTICLE
Evelyn Mianes Besckow, Kauane Nayara Bahr Ledebuhr, Camila Simões Pires, Marcia Juciele da Rocha, Natália Emanuele Biolosor Kuntz, Benhur Godoi, Cristiani Folharini Bortolatto, César Augusto Brüning
The compound N -(3-(phenylselanyl)prop-2-yn-1-yl)benzamide (SePB), which combines a selenium atom and a benzamide nucleus in an organic structure, has demonstrated a fast antidepressant-like effect in mice. This action is influenced by the serotonergic system and represents a promising development in the search for novel antidepressant drugs to treat major depressive disorder (MDD), which often resists conventional treatments. This study aimed to further explore the mechanism underlying the antidepressant-like effect of SePB by investigating the involvement of the dopaminergic and noradrenergic systems in the tail suspension test (TST) in mice and evaluating its pharmacokinetic profile in silico...
April 19, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38636702/reserpine-induced-rat-model-for-depression-behavioral-physiological-and-pet-based-dopamine-receptor-availability-validation
#12
JOURNAL ARTICLE
Lidia Miguel Telega, Raissa Berti, Ganna Blazhenets, Lisa-Charlotte Domogalla, Nils Steinacker, M Aymen Omrane, Philipp T Meyer, Volker A Coenen, Ann-Christin Eder, Máté D Döbrössy
BACKGROUND: Reserpine (RES), a Vesicular Monoamine Transporter 2 (VMAT2 ) inhibitor agent, has been used in preclinical research for many years to create animal models for depression and to test experimental antidepressant strategies. Nevertheless, evidence of the potential use and validity of RES as a chronic pharmacological model for depression is lacking, and there are no comprehensive studies of the behavioral effects in conjunction with molecular outcomes. METHODS: Experiment 1...
April 16, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/38635745/dopamine-d2-receptor-antagonist-counteracts-hyperglycemia-and-insulin-resistance-in-diet-induced-obese-male-mice
#13
JOURNAL ARTICLE
Dina I Vázquez-Carrillo, Ana Luisa Ocampo-Ruiz, Arelí Báez-Meza, Gabriela Ramírez-Hernández, Elva Adán-Castro, José Fernando García-Rodrigo, José Luis Dena-Beltrán, Ericka A de Los Ríos, Magdalena Karina Sánchez-Martínez, María Georgina Ortiz, Gonzalo Martínez de la Escalera, Carmen Clapp, Yazmín Macotela
Obesity leads to insulin resistance (IR) and type 2 diabetes. In humans, low levels of the hormone prolactin (PRL) correlate with IR, adipose tissue (AT) dysfunction, and increased prevalence of T2D. In obese rats, PRL treatment promotes insulin sensitivity and reduces visceral AT adipocyte hypertrophy. Here, we tested whether elevating PRL levels with the prokinetic and antipsychotic drug sulpiride, an antagonist of dopamine D2 receptors, improves metabolism in high fat diet (HFD)-induced obese male mice. Sulpiride treatment (30 days) reduced hyperglycemia, IR, and the serum and pancreatic levels of triglycerides in obese mice, reduced visceral and subcutaneous AT adipocyte hypertrophy, normalized markers of visceral AT function (PRL receptor, Glut4, insulin receptor and Hif-1α), and increased glycogen stores in skeletal muscle...
2024: PloS One
https://read.qxmd.com/read/38632622/ivermectin-increases-striatal-cholinergic-activity-to-facilitate-dopamine-terminal-function
#14
JOURNAL ARTICLE
Hillary A Wadsworth, Alicia M P Warnecke, Joshua C Barlow, J Kayden Robinson, Emma Steimle, Joakim W Ronström, Pacen E Williams, Christopher J Galbraith, Jared Baldridge, Michael W Jakowec, Daryl L Davies, Jordan T Yorgason
Ivermectin (IVM) is a commonly prescribed antiparasitic treatment with pharmacological effects on invertebrate glutamate ion channels resulting in paralysis and death of invertebrates. However, it can also act as a modulator of some vertebrate ion channels and has shown promise in facilitating L-DOPA treatment in preclinical models of Parkinson's disease. The pharmacological effects of IVM on dopamine terminal function were tested, focusing on the role of two of IVM's potential targets: purinergic P2X4 and nicotinic acetylcholine receptors...
April 17, 2024: Cell & Bioscience
https://read.qxmd.com/read/38629943/current-and-emerging-pharmacotherapy-for-the-treatment-of-gastroparesis
#15
REVIEW
M Ammar Kalas, Irene Sarosiek, Richard W McCallum
INTRODUCTION: Gastroparesis is a chronic disorder characterized by decreased gastric emptying and presents with nausea, vomiting, and abdominal pain which impacts patients' quality of life greatly. The treatment modalities available for gastroparesis have been expanding over the past 2 decades. Currently there are multiple options available for gastroparesis albeit with only one FDA approved medication until June of 2021. AREAS COVERED: We review the different treatments available for gastroparesis and discuss the recently FDA approved intranasal formulation of metoclopramide...
April 17, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38629703/understanding-the-therapeutic-action-of-antipsychotics-from-molecular-to-cellular-targets-with-focus-on-the-islands-of-calleja
#16
JOURNAL ARTICLE
Merve Direktor, Peter Gass, Dragos Inta
The understanding of the pathophysiology of schizophrenia as well as the mechanisms of action of antipsychotic drugs remains a challenge for psychiatry. The demonstration of the therapeutic efficacy of several new atypical drugs targeting multiple different receptors apart from the classical dopamine D2 receptor as initially postulated unique antipsychotic target, complicated even more conceptualization efforts. Here we discuss results suggesting a main role of the islands of Calleja, still poorly studied GABAergic granule cell clusters in the ventral striatum, as cellular targets of several innovative atypical antipsychotics (clozapine, cariprazine and xanomeline/emraclidine) effective in treating also negative symptoms of schizophrenia...
April 17, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38627765/attenuating-mitochondrial-dysfunction-and-morphological-disruption-with-pt320-delays-dopamine-degeneration-in-mitopark-mice
#17
JOURNAL ARTICLE
Vicki Wang, Kuan-Yin Tseng, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Lun Lan, Zi-Rong Chen, Kuo-Hsing Ma, Nigel H Greig, Jin Jung, Ho-Ii Choi, Lars Olson, Barry J Hoffer, Yuan-Hao Chen
BACKGROUND: Mitochondria are essential organelles involved in cellular energy production. Changes in mitochondrial function can lead to dysfunction and cell death in aging and age-related disorders. Recent research suggests that mitochondrial dysfunction is closely linked to neurodegenerative diseases. Glucagon-like peptide-1 receptor (GLP-1R) agonist has gained interest as a potential treatment for Parkinson's disease (PD). However, the exact mechanisms responsible for the therapeutic effects of GLP-1R-related agonists are not yet fully understood...
April 17, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38626866/mechanisms-of-neurocentral-eyestalk-intestinal-immunotoxicity-in-whiteleg-shrimp-litopenaeus-vannamei-under-ammonia-nitrogen-exposure
#18
JOURNAL ARTICLE
Ruixue Tong, Yaobing Li, Xin Yu, Ning Zhang, Qilong Liao, Luqing Pan
Ammonia-N, as the most toxic nitrogenous waste, has high toxicity to marine animals. However, the interplay between ammonia-induced neuroendocrine toxicity and intestinal immune homeostasis has been largely overlooked. Here, a significant concordance of metabolome and transcriptome-based "cholinergic synapse" supports that plasma metabolites acetylcholine (ACh) plays an important role during NH4 Cl exposure. After blocking the ACh signal transduction, the release of dopamine (DA) and 5-hydroxytryptamine (5-HT) in the cerebral ganglia increased, while the release of NPF in the thoracic ganglia and NE in the abdominal ganglia, and crustacean hyperglycemic hormone (CHH) and neuropeptide F (NPF) in the eyestalk decreased, finally the intestinal immunity was enhanced...
April 14, 2024: Environmental Pollution
https://read.qxmd.com/read/38624263/attention-deficit-hyperactivity-disorder-and-dopamine-receptor-d4-drd4-exon-3-variable-number-of-tandem-repeats-vntr-2-repeat-allele
#19
JOURNAL ARTICLE
Larry Baum, Chi Chiu Lee, Rui Ye, Yuanxin Zhong, Se Fong Hung, Chun Pan Tang, Ting Pong Ho, James M Swanson, Robert K Moyzis, Pak-Chung Sham, Patrick Wing-Leung Leung
To investigate the association of attention-deficit/hyperactivity disorder (ADHD) with the 48-base pair (bp) variable number of tandem repeats (VNTR) in exon 3 of the dopamine receptor D4 (DRD4) gene, we genotyped 240 ADHD patients and their parents from Hong Kong. The 4R allele was most common, followed by 2R. We examined association between the 2R allele (relative to 4R) and ADHD by Transmission Disequilibrium Test (TDT). The odds ratio (OR) (95% confidence interval) was 0.90 (0.64-1.3). The p-value was 0...
April 16, 2024: Annals of Human Genetics
https://read.qxmd.com/read/38623339/a-dopamine-d1-like-receptor-specific-agonist-improves-the-survival-of-septic-mice
#20
JOURNAL ARTICLE
Koichi Tanaka, Mohammed E Choudhury, Satoshi Kikuchi, Ikuko Takeda, Kensuke Umakoshi, Noriyuki Miyaue, Kanta Mikami, Ayane Takenaga, Harumichi Yagi, Rintaro Shinabe, Hironori Matsumoto, Hajime Yano, Masahiro Nagai, Jun Takeba, Junya Tanaka
In this study, a murine sepsis model was developed using the cecum ligation and puncture (CLP) technique. The expression of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) in the brain increased 6 h after CLP but decreased 24 h later when elevated endogenous dopamine levels in the brain were sustained. Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride reduced dopamine levels in the striatum and increased mortality in septic mice...
April 19, 2024: IScience
keyword
keyword
63591
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.